Showing results (101-110 of 258) with videos related to
Sort By:
Pageof 26
Current Problems in Cancer|April 4, 2025
Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failureYoh Yamaguchi, Yuki Shinno, Ken Masuda, et al.Oncology Letters|June 7, 2013
Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumoniaTakashi Kinoshita, Koichi Azuma, Tetsuro Sasada, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.Cardiovascular Research|November 6, 2013
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertensionHiromichi Wakui, Toru Dejima, Kouichi Tamura, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 6, 2010
Sustained inhibition of oxidized low-density lipoprotein is involved in the long-term therapeutic effects of apheresis in dialysis patientsYuko Tsurumi-Ikeya, Kouichi Tamura, Koichi Azuma, et al.Plos One|February 6, 2013
IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13Masanori Sawada, Tomotaka Kawayama, Haruki Imaoka, et al.Molecular Cancer Therapeutics|December 4, 2016
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung CancerYoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 22, 2008
Ambulatory blood pressure variability is increased in diabetic hypertensivesMotoko Ozawa, Kouichi Tamura, Kousaku Iwatsubo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2015
Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung CancerKeiichi Ota, Koichi Azuma, Akihiko Kawahara, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 28, 2012
An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirinEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Pageof 26